Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy

od Shlamkovich, Tomer, Aharon, Lidan, Barton, William A., Papo, Niv
Wydane w Oncotarget (2017)

Targeting the Tie2–α(v)β(3) integrin axis with bi-specific reagents for the inhibition of angiogenesis

od Shlamkovich, Tomer, Aharon, Lidan, Koslawsky, Dana, Einav, Yulia, Papo, Niv
Wydane w BMC Biol (2018)